Subscribe To

Price Alert Latest News Economic Calendar News

GDBYF / Goodbody Health to re-domicle in Guernsey and de-list from CSX

Goodbody Health said it is to de-list from the Canadian Stock Exchange (CSE), re-domicile to Guernsey and appoint Peterhouse as its corporate adviser “This re-domiciliation is intended to better align Goodbody's corporate structure with its current and future business activities,” it said in a statement. The company already has a substantial business presence in the UK and the European Union, it added, including all of its operations, management and workforce. Read More

Demo Live Account See Partner Details

Content Topics

Goodbody

Health

Re

Domicle

Guernsey

De

List

From

Re domicle

De list

Stock

GDBYF

Posted: Jun 10 2022, 10:44

Author Name: Proactive Investors

GDBYF News

By Proactive Investors
April 21, 2023

Goodbody Health makes strategic strides

Goodbody Health Ltd (AQSE:GDBY) said its 2022 results reflect its successful diversification as it added a wider range of diagnostic tests and began t

By Proactive Investors
March 16, 2023

Goodbody Health launches mobile blood testing service

Goodbody Health has launched its new mobile phlebotomy service to “develop and increase” the reach of phlebotomy testing. Phlebotomy is a procedur

By Proactive Investors
February 15, 2023

Goodbody Health extends phlebotomy services with contract win

Goodbody Health signed a contract with blood testing company Thriva as it continues to make progress on extending its phlebotomy services. A phlebotom

By Proactive Investors
January 26, 2023

Goodbody Health to offer multi-cancer screening services via liquid biopsy test

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its network of UK clinics will start offering multi-cancer screening service, as part of a partnersh

By Proactive Investors
December 30, 2022

Goodbody Health reports boardroom changes

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) has announced that its chair Geremy Thomas will be stepping down from his executive duties, effective 1st

By Proactive Investors
December 16, 2022

Goodbody Health sells Polish CBD facility

Goodbody Health has agreed to sell its Polish CBD-related operations to Voyager Life for £1.5mln, comprising £0.5m cash and £1mln of convertible lo

By Proactive Investors
December 1, 2022

Goodbody Health announces appointment of George Thomas as its chief executive officer with immediate effect

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) has announced that George Thomas, an existing executive director of the company and managing director of

By Proactive Investors
November 11, 2022

Goodbody Health turns focus to preventative diagnostics

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its focus is now on preventative diagnostics as it looks to become a “leading aggregator” of inn

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.